Format

Send to

Choose Destination
See comment in PubMed Commons below
Cancer Lett. 2012 Feb 28;315(2):122-8. doi: 10.1016/j.canlet.2011.07.021. Epub 2011 Aug 5.

Carnosine inhibits KRAS-mediated HCT116 proliferation by affecting ATP and ROS production.

Author information

1
Dipartimento di Biochimica e Biotecnologie Mediche, Università di Napoli "Federico II", 80131 Napoli, Italy.

Abstract

Carnosine is a natural dipeptide that has generated particular interest for its antioxidant, anti-aging and especially for its antiproliferative properties. In this study, we demonstrate that carnosine inhibits the proliferation of human HCT116 colon cancer cells. In this cell line, the activating KRAS mutation induces mitochondrial ROS, the signaling molecules for cell proliferation. We observed that 50-100 mM carnosine decreases ATP and ROS concentration and induces cell cycle arrest in G1 phase. In HCT116 cells these effects are related to decreased ERK1/2 phosphorylation and increased p21waf1 protein. Our findings support the concept that carnosine could inhibit HCT116 cell growth via its antioxidant activity and its ability to affect glycolysis.

PMID:
22137144
DOI:
10.1016/j.canlet.2011.07.021
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center